FOXO4-DRI

Senolytic Research Peptide for Cellular Senescence & FOXO4 Signalling

FOXO4-DRI is an experimental synthetic peptide that has attracted significant scientific interest due to its interaction with FOXO4 (Forkhead Box O4), a protein involved in cellular stress responses, DNA repair and cell survival regulation.

The compound has been investigated for its potential role in cellular senescence research, particularly its interaction with pathways that influence the survival of senescent cells. Researchers study FOXO4-DRI in laboratory models examining cellular ageing, apoptosis, senescence-associated signalling and tissue biology.

Key Features

✓ Studied for its interaction with FOXO4-related signalling pathways
✓ Frequently researched in cellular senescence models
✓ Investigated for its potential senolytic properties
✓ Explored in apoptosis and cellular survival research
✓ Studied in ageing-related cellular mechanisms
✓ Relevant to longevity and cellular biology research

Cellular Senescence Research

FOXO4-DRI is investigated in laboratory models examining cellular senescence, a biological process in which cells permanently stop dividing while remaining metabolically active.

Research explores how FOXO4-related signalling may contribute to the survival of senescent cells.

FOXO4 Signalling Research

Researchers study the interaction between FOXO4 and p53, a protein involved in cellular stress responses and apoptosis.

FOXO4-DRI was developed as a research tool to investigate this protein interaction and its potential influence on senescent cell survival.

Apoptosis Research

Research explores the mechanisms involved in programmed cell death and how disruption of specific protein interactions may influence cellular survival pathways.

Longevity & Cellular Ageing Studies

FOXO4-DRI has attracted interest in experimental ageing research, particularly studies investigating senescent cell accumulation and the biological mechanisms associated with cellular ageing.

Scientific Research Context

Cellular senescence is an important biological process associated with ageing, tissue maintenance and cellular stress responses.

Senescent cells can accumulate in tissues over time and release a collection of signalling molecules known as the senescence-associated secretory phenotype (SASP).

FOXO4 is a transcription factor involved in several cellular processes, including stress resistance, DNA damage responses and cell survival.

FOXO4-DRI is an experimental peptide designed to interfere with the interaction between FOXO4 and p53. This makes it a research compound of interest in studies investigating:

• FOXO4 and p53 protein interactions
• Cellular senescence mechanisms
• Apoptosis and programmed cell death
• Senescent cell survival pathways
• Age-related cellular changes
• Cellular stress responses
• Longevity-related biological mechanisms
• Senolytic research pathways

These research areas continue to contribute to scientific interest in FOXO4-DRI and its potential role in cellular ageing research.

Common Research Applications

FOXO4-DRI is investigated in laboratory research models involving:

• Cellular senescence
• FOXO4 signalling pathways
• p53-related protein interactions
• Apoptosis mechanisms
• Senescent cell biology
• Cellular stress responses
• Ageing-related research
• Senolytic compound development

Related Research Compounds

Researchers investigating cellular ageing and senescence-related pathways may also study:

• Epitalon – telomere biology and cellular ageing research.
• Thymosin Alpha-1 – immune signalling and cellular regulation research.
• MOTS-C – mitochondrial signalling and metabolic adaptation research.
• GHK-Cu – cellular repair, tissue biology and gene expression research.

These compounds are investigated through different mechanisms within cellular biology, ageing and longevity research.

Product Specifications

Product Name: FOXO4-DRI
Compound Type: Experimental Synthetic Peptide
Research Category: Cellular Senescence & Longevity Research
Primary Target: FOXO4-p53 Protein Interaction
Physical Form: Research Grade Powder
Available Sizes: 5mg, 10mg and 20mg Vials
Application: Scientific Research Use Only

Important Notice

For laboratory research use only. This product is intended solely for research, analytical and educational purposes. It is not intended for human or animal consumption, anti-ageing treatment, therapeutic use, veterinary use, diagnostic procedures or administration of any kind.

FOXO4-DRI remains an experimental research peptide. Its safety, efficacy and long-term effects in humans have not been established through adequate clinical research.